drugset / Trial / NCT06081166
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Non-randomizedSequentialOpen-labelTreatment
Summary
A study to evaluate impact of Obicetrapib on PK levels of Atorvastatin and Rosuvastatin
Timeline
- Start
- 2023-11-11
- Primary completion
- 2023-12-02
- Completion
- 2024-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin 80 mg | Unknown | 80 mg | — |
| Comparator | Obicetrapib | Small molecule | 10 mg | — |
| Comparator | Rosuvastatin 40 mg | Unknown | 40 mg | — |
Indications
No indication recorded.